Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4

Journal of Immunology

Volumn 192, Issue 1, 2014, Pages 523-532

  Volonté, Andrea ^a   Di Tomaso, Tiziano ^a   Spinelli, Michela ^a   Todaro, Matilde ^b   Sanvito, Francesca ^a   Albarello, Luca ^a   Bissolati, Massimiliano ^a   Ghirardelli, Luca ^a   Orsenigo, Elena ^a   Ferrone, Soldano ^c   Doglioni, Claudio ^a   Stassi, Giorgio ^b   Dellabona, Paolo ^a   Staudacher, Carlo ^a   Parmiani, Giorgio ^a   MacCalli, Cristina ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LGR5 PROTEIN; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL CONTACT; CELL ISOLATION; CELL STIMULATION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSURVEILLANCE; IN VITRO STUDY; INHIBITION KINETICS; MEMBRANE BINDING; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR ESCAPE;

EID: 84891121499     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301342     Document Type: Article

References (33)

1. Clevers, H. 2011. The cancer stem cell: premises, promises and challenges. Nat. Med. 17: 313-319.
2. Ricci-Vitiani, L., E. Fabrizi, E. Palio, and R. De Maria. 2009. Colon cancer stem cells. J. Mol. Med. 87: 1097-1104.
3. Wilson, B. J., T. Schatton, M. H. Frank, and N. Y. Frank. 2011. Colorectal cancer stem cells: biology and therapeutic implications. Curr Colorectal Cancer Rep 7: 128-135.
4. Bao, S., Q. Wu, R. E. McLendon, Y. Hao, Q. Shi, A. B. Hjelmeland, M. W. Dewhirst, D. D. Bigner, and J. N. Rich. 2006. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
5. Eramo, A., L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti, G. Sette, E. Pilozzi, L. M. Larocca, C. Peschle, and R. De Maria. 2006. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 13: 1238-1241.
6. Diehn, M., and M. F. Clarke. 2006. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J. Natl. Cancer Inst. 98: 1755-1757.
7. Ellebaek, E., M. H. Andersen, I. M. Svane, and P. T. Straten. 2012. Immunotherapy for metastatic colorectal cancer: present status and new options. Scand. J. Gastroenterol. 47: 315-324.
8. Irvin, D. K., E. Jouanneau, G. Duvall, X. X. Zhang, Y. Zhai, D. Sarayba, A. Seksenyan, A. Panwar, K. L. Black, and C. J. Wheeler. 2010. T cells enhance stem-like properties and conditional malignancy in gliomas. PLoS ONE 5: e10974.
9. Noh, K.H., Y. H. Lee, J.H. Jeon, T. H. Kang, C. P. Mao, T. C. Wu, and T.W. Kim. 2012. Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype. Cancer Res. 72: 1717-1727.
10. Di Tomaso, T., S. Mazzoleni, E. Wang, G. Sovena, D. Clavenna, A. Franzin, P. Mortini, S. Ferrone, C. Doglioni, F. M. Marincola, et al. 2010. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin. Cancer Res. 16: 800-813.
11. Podberezin, M., J. Wen, and C. C. Chang. 2013. Cancer stem cells: a review of potential clinical applications. Arch. Pathol. Lab. Med. 137: 1111-1116.
12. Wei, J., J. Barr, L.-Y. Kong, Y. Wang, A. Wu, A. K. Sharma, J. Gumin, V. Henry, H. Colman, R. Sawaya, et al. 2010. Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 16: 461-473.
13. Schatton, T., and M. H. Frank. 2009. Antitumor immunity and cancer stem cells. Ann. N. Y. Acad. Sci. 1176: 154-169.
14. Roth, P., M. Junker, I. Tritschler, M. Mittelbronn, Y. Dombrowski, S. N. Breit, G. Tabatabai, W. Wick, M. Weller, and J.Wischhusen. 2010. GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clin. Cancer Res. 16: 3851-3859.
15. Maccalli, C., Y. F. Li, M. El-Gamil, S. A. Rosenberg, and P. F. Robbins. 2003. Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes. Cancer Res. 63: 6735-6743.
16. Maccalli, C., V. Di Cristanziano, V. Fodale, D. Corsi, G. D'Agostino, V. Petrangeli, L. Laurenti, S. Guida, A. Mazzocchi, F. Arienti, et al. 2008. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1. Clin. Cancer Res. 14: 7292-7303.
17. Mazzoleni, S., L. S. Politi, M. Pala, M. Cominelli, A. Franzin, L. Sergi Sergi, A. Falini, M. De Palma, A. Bulfone, P. L. Poliani, and R. Galli. 2010. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 70: 7500-7513.
18. Lee, J., S. Kotliarova, Y. Kotliarov, A. Li, Q. Su, N. M. Donin, S. Pastorino, B. W. Purow, N. Christopher, W. Zhang, et al. 2006. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
19. Todaro, M., M. P. Alea, A. B. Di Stefano, P. Cammareri, L. Vermeulen, F. Iovino, C. Tripodo, A. Russo, G. Gulotta, J. P. Medema, and G. Stassi. 2007. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402.
20. Vermeulen, L., M. Todaro, F. de Sousa Mello, M. R. Sprick, K. Kemper, M. Perez Alea, D. J. Richel, G. Stassi, and J. P. Medema. 2008. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. USA 105: 13427-13432.
21. Dalerba, P., S. J. Dylla, I. K. Park, R. Liu, X. Wang, R. W. Cho, T. Hoey, A. Gurney, E. H. Huang, D. M. Simeone, et al. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 104: 10158-10163.
22. Huang, E. H., M. J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J. Z. Fields, M. S. Wicha, and B. M. Boman. 2009. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69: 3382-3389.
23. Abdul Khalek, F. J., G. I. Gallicano, and L. Mishra. 2010. Colon cancer stem cells. Gastrointest Cancer Res (Suppl 1): S16-S23.
24. Kemper, K., P. R. Prasetyanti, W. De Lau, H. Rodermond, H. Clevers, and J. P. Medema. 2012. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells 30: 2378-2386.
25. Francipane, M. G., M. P. Alea, Y. Lombardo, M. Todaro, J. P. Medema, and G. Stassi. 2008. Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res. 68: 4022-4025.
26. Novellino, L., C. Castelli, and G. Parmiani. 2005. A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol. Immunother. 54: 187-207.
27. Dieter, S. M., C. R. Ball, C. M. Hoffmann, A. Nowrouzi, F. Herbst, O. Zavidij, U. Abel, A. Arens, W. Weichert, K. Brand, et al. 2011. Distinct types of tumorinitiating cells form human colon cancer tumors and metastases. Cell Stem Cell 9: 357-365.
28. Hjelmeland, A. B., and J. N. Rich. 2012. The quest for self-identity: not all cancer stem cells are the same. Clin. Cancer Res. 18: 3495-3498.
29. Muraro, M. G., V. Mele, S. Däster, J. Han, M. Heberer, G. Cesare Spagnoli, and G. Iezzi. 2012. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Stem Cells Transl Med 1: 592-603.
30. Kim, S.-Y., H.-S. Cho, S.-H. Yang, J.-Y. Shin, J.-S. Kim, S.-T. Lee, K. Chu, J. K. Roh, S. U. Kim, and C. G. Park. 2009. Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation. J. Neurosci. Res. 87: 2264-2272.
31. Tallerico, R., M. Todaro, S. Di Franco, C. Maccalli, C. Garofalo, R. Sottile, C. Palmieri, L. Tirinato, P. N. Pangigadde, R. La Rocca, et al. 2013. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J. Immunol. 190: 2381-2390.
32. De Palma, M. 2012. Partners in crime: VEGF and IL-4 conscript tumourpromoting macrophages. J. Pathol. 227: 4-7.
33. Hallett, M. A., K. T. Venmar, and B. Fingleton. 2012. Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res. 72: 6338-6343.